Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20993)	5/17/1998 6:03:00 PM
From: Machaon	Respond to of 32384

<< The Roche patent issue has been in LGND's filings for several years >> Yes, I know. But, the fact that it is still an issue, means that it hasn't gone away. And....... if it hasn't been put to bed for a couple of years, it means, to me, that it has a certain complexity about it. Apparantly, to LGND, it is not a big enough issue to stop their progress with Panretin. But, it is still like a small splinter in the foot of the LGND stock. Regards, Bob